BlinkLab

Large-Scale Study Validates and Enhances BlinkLab’s Accuracy in Detecting Autism in Children

BlinkLab Limited (ASX:BB1) (“BlinkLab” or the “Company”), an innovative digital healthcare company developing smartphone-based AI powered diagnostic tests for autism and other neurological conditions, is excited to announce results from the latest study in autism confirming high-accuracy in detecting autism in children ahead of upcoming FDA registrational study.


Highlights

  • Analysis of a study conducted in 441 children diagnosed for autism using current standard-of-care protocols showed that ‘BlinkLab Dx 1’ detected autism with an improved sensitivity of 91% and specificity of 85%.
  • These results bolster confidence that BlinkLab Dx 1 will surpass the accuracy parameters required for regulatory approval in the upcoming FDA registration trial, scheduled to commence by the end of this calendar year.
  • The study is an expansion of the prior study conducted by BlinkLab, in partnership with the Turning Pointe Autism Foundation in Illinois, Princeton University, and the National Center for the Disabled in Morocco. The study was undertaken using the latest version of our digital diagnostic platform, BlinkLab Dx 1, that includes a novel set of digital biomarkers and refined machine learning models.
  • This new data highlights BlinkLab Dx 1 potential as a rapid accurate test in the growing autism diagnostics market which is expected to reach $5.41 billion by 2036. A recent industry report shows families face a three-year average wait for autism assessments and 21% of U.S. clinics are unable to accept new referrals due to high demand.

About the study

A multi-center, within-subject comparison study was conducted on 441 children aged 4 to 12 years, including 285 diagnosed with autism and 156 without. This sample size far exceeded the minimum required to power the study for statistical significance.

The study was conducted in accordance with all relevant guidelines and regulations and received approval from the institutional review boards of Princeton University (#13943) and the Faculté de Médecine et de Pharmacie de Marrakech in Morocco (#23/2022).

All neurobehavioral tests were administered using the BlinkLab smartphone-based platform. Assessments included general measures of spontaneous and stimulus-evoked postural, head, facial and vocal responses, as well as specific neurometric tests like prepulse inhibition and startle habituation. Each child completed two 15-minute sessions while watching an engaging video content, with auditory stimuli delivered via headphones. During each session, computer vision algorithms tracked and recorded the position of the children’s facial landmarks over time. Analysing spontaneous and stimulus-evoked responses along with prepulse inhibition and startle habituation performance, our machine learning algorithms achieved a sensitivity of 91% and specificity of 85%. This is a substantial improvement compared to the 85% and 84%, respectively, we reported in our previous study (ASX Announcement, 2 April 2024 – BlinkLab Prospectus 2024, page 47). The BlinkLab Dx 1 model also demonstrated robust and consistent performance across gender and age groups.

The results indicate that BlinkLab’s smartphone-based testing effectively identifies sensory sensitivities in children with autism, highlighting the potential of non-invasive digital biomarkers as a diagnostic aid for autism. Additionally, they reflect the benefits of BlinkLab's institutional collaborations over the past year, which have contributed to the ongoing training and refinement of our diagnostic models.

Significance of the project

Deficits in sensory processing represent a core feature of autism, which is typically assessed through subjective observations such as questionnaires or parent-child interviews and are susceptible to geographic and socio-economic biases. An objective approach to quantify sensory sensitivity is now possible through digital neurometric evaluations. The clinical application of these sensory assessments has been confined largely to laboratory settings that use fixed equipment to provide a stable test environment making it impossible to use at scale for clinical diagnosis. This study demonstrates that fast, scientifically validated smartphone- based tests can be widely deployed in clinical settings remotely and at scale. Unlike current time-intensive and costly multidisciplinary assessments which rely on specialist expertise and are often difficult to access, BlinkLab Dx1 test offers a more efficient and accessible alternative. Current wait times for a formal autism diagnosis using standard-of-care methods often extend up to three years, with individual assessments taking as long as eight hours to complete. Studies show that these delays impose a significant economic and healthcare burden on affected families and communities.


Click here for the full ASX Release

This article includes content from Blinklab Limited, licensed for the purpose of publishing on Investing News Australia. This article does not constitute financial product advice. It is your responsibility to perform proper due diligence before acting upon any information provided here. Please refer to our full disclaimer here.

BB1:AU
The Conversation (0)
AI text over a vibrant, futuristic, technological background with dynamic lines and symbols.

AI Market Update: Q2 2025 in Review

Q2 confirmed that the artificial intelligence (AI) boom is entering a new phase in the physical world.

As the industry evolves, attention is being directed to strengthening underlying infrastructure while advancing areas like embodied AI, a subsector that MarketsandMarkets projects will grow at a CAGR of 39 percent globally by 2030.

Also during Q2, a geopolitical tech rivalry exacerbated shifting macroeconomic conditions.

Keep reading...Show less
NVIDIA logo with blurred graphics cards in background, black and green theme.

Nvidia’s US$4 Trillion Surge Signals AI Chip Supremacy: Report

Nvidia's (NASDAQ:NVDA) brief but historic rise to a US$4 trillion market capitalization last week underscores a dramatic shift in global technology leadership—and signals that AI chips are now the backbone of the digital economy, according to GlobalData.

While industry giants Apple (NASDAQ:AAPL) and Microsoft (NASDAQ:MSFT) had previously vied for tech supremacy, Nvidia’s meteoric growth—driven by the AI boom—has placed it firmly at the center of the global semiconductor race.

Keep reading...Show less
NVIDIA logo, stock chart with green upward arrow.

Tech 5: NVIDIA Hits Market Cap Milestone, Harmonic Raises US$100 Million

NVIDIA (NASDAQ:NVDA) became the first publicly traded company to hit a US$4 trillion market cap this week.

Meanwhile, Apple (NASDAQ:AAPL) made headlines with a major leadership change as rumors of a lineup of upcoming product releases circulated, and Meta Platforms (NASDAQ:META) deepened ties with one of its hardware partners.

In the chip market, Huawei is trying to capitalize on the gap left by NVIDIA's chips in China, while a startup is stepping up its efforts to help meet its ambitious plans to expand artificial intelligence (AI) chip delivery to Saudi Arabia.

Keep reading...Show less
Gloved hand installing a CPU onto a circuit board, labeled "Tech 5" with network graphic.

Tech 5: US Lifts EDA Restrictions for China, Apple Explores Third-party AI for Siri

The stock market had a dynamic start to Q3, pushing indexes to new highs after earlier tariff concerns.

On Monday (June 30), markets generally saw strong gains, with the S&P 500 (INDEXSP:INX) and Nasdaq Composite (INDEXNASDAQ:.IXIC) reaching new record highs in the US, while the S&P/TSX Composite Index (INDEXTSI:OSPTX) climbed higher after a last-minute policy reversal to rescind a planned digital services tax targeting US tech firms.

Canadian markets were closed for Canada Day on Tuesday (July 1). As for US markets, following two consecutive days of highs, the S&P 500 and Nasdaq Composite declined after a renewed feud between Tesla (NASDAQ:TSLA) CEO Elon Musk and US President Donald Trump sent Tesla shares down by over 5 percent.

Keep reading...Show less
Syntheia (CSE:SYAI)

Syntheia


Keep reading...Show less
Logos of OpenAI and Microsoft with "Tech 5" on an abstract tech-themed background.

Tech 5: OpenAI/Microsoft Talks Get Tense, SoftBank Floats Arizona Robotics Hub

This week, Microsoft (NASDAQ:MSFT) and OpenAI's once tight alliance showed signs of strain, while Meta Platforms (NASDAQ:META) continued to source artificial intelligence (AI) talent from rival companies.

Meanwhile, SoftBank's (TSE:9434) CEO is considering a new chip and robotics venture in Arizona, and Google (NASDAQ:GOOGL) is looking to bring AI solutions to American cities.

Read on to dive deeper into this week's top tech stories.

Keep reading...Show less

Latest Press Releases

Related News

×